Aflac Global Ventures

Aflac Global Ventures serves as the strategic corporate venture capital arm of Aflac Inc., a leading provider of supplemental health insurance and a Fortune 500 company. Established to foster innovation and identify strategic opportunities, the firm focuses its investments on companies operating within the health technology, insurtech, and cancer care sectors. Its primary objective is to support startups that can enhance Aflac's core business, improve customer experience, drive operational efficiencies, or provide insights into emerging market trends. This strategic alignment ensures that investments are not only financially promising but also offer potential for synergistic partnerships with the parent company.

The venture arm actively seeks out early to growth-stage companies, typically participating in Seed, Series A, and Series B funding rounds. Aflac Global Ventures aims to be a value-add investor, offering more than just capital. Portfolio companies gain access to Aflac's extensive industry expertise, vast network, and potential for commercial collaborations, which can accelerate their growth and market penetration. The firm's investment thesis is rooted in identifying pioneering solutions that can redefine the future of insurance and healthcare, aligning with Aflac's commitment to innovation and customer well-being.

Since its inception, Aflac Global Ventures has demonstrated a consistent investment pace. The fund, which was initially announced with a commitment of $100 million in 2019, has actively deployed capital across its target sectors. Typical initial investments from Aflac Global Ventures range from $1 million to $10 million, reflecting their engagement with both nascent and more established startups. As of late 2023, the firm has made over 25 investments, building a diverse portfolio of companies that are at the forefront of healthcare and insurance innovation. Their commitment extends beyond initial funding, often including follow-on investments to support the continued development and scaling of their portfolio companies.